Pediatric Blood & Cancer is the joint ASPHO and SIOP journal for childhood cancer and blood disorders, publishing cooperative-group trial reports, late effects and supportive care.
Pediatric Blood & Cancer appears monthly and publishes Children's Oncology Group and SIOP trial analyses, survivorship and late-effects cohorts, supportive-care guidelines and global paediatric oncology research. Formed in 2004 from Medical and Pediatric Oncology and the Journal of Pediatric Hematology/Oncology lineage. Hybrid access via Wiley.
A reminder that ivermectin interacts with cancer drugs: the dose that a healthy adult tolerates can poison a patient whose liver enzymes are already occupied by a kinase inhibitor.
One cancer page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
One cancer page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Polish medical oncologist and sarcoma specialist who serves as President of the Organisation of European Cancer Institutes.
Medical oncologist who has led the Uganda Cancer Institute in Kampala, East Africa's principal cancer research and treatment centre.
Paediatric oncologist and certified physician executive who has led CancerCare Manitoba, the provincial cancer agency, as President and CEO since November 2025.
Marco Guzzo is a head and neck surgeon at INT Milan.
Paediatric oncologist and neuroblastoma researcher who serves as Paediatrician-in-Chief at SickKids in Toronto.
Neuroblastoma expert who built the international risk classification used to guide treatment.
Paediatric oncologist and palliative care physician serving as Interim Director of Texas Children's Cancer and Hematology Center.
Clinician at Watford General Hospital who is President of the Histiocyte Society, the international research society for histiocytic disorders, for the 2025 to 2028 term.
A reminder that ivermectin interacts with cancer drugs: the dose that a healthy adult tolerates can poison a patient whose liver enzymes are already occupied by a kinase inhibitor.
One cancer page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
One cancer page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.
Shares St Jude Lifetime Cohort Study (SJLIFE), Late effects and survivorship toxicity.